Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 501–600 of 965
The Human Microbiome as a Therapeutic Target for Metabolic Diseases
Bui, T. P. N. (2024) · Nutrients · doi:10.3390/nu16142322 · Cited by 12
Zhou, Y., Liu, S., Zhang, Q., Zhang, S., Wu, S., & Zhu, S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15852 · Cited by 11
“8,9 Second, hypergly-caemia could impair the autonomic nervous system of the gut, leading to dysfunction of gut motility and visceral hypersensitivity.”
Zhang, Y., Li, X., Xu, S., Li, J., Shi, L., Wang, Z., Chen, P., Jia, L., & Zhang, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140055 · Cited by 11
Wu, K., Yang, X. F., Zhang, T., Bai, Y., & Yan, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-02824-9 · Cited by 11
Vacca, A., Brosolo, G., Marcante, S., Mora, S. D., Bulfone, L., Porto, A. D., Pagano, C., Catena, C., & Sechi, L. A. (2026) · Nutrients · doi:10.3390/nu18020321 · Cited by 13
“Mechanistic studies suggest that hyperglycemia itself can increase intestinal permeability via GLUT2-mediated transcriptional changes and disruption of tight junctions, creating a “leaky gut” that may promote systemic inflammation and insulin resistance [141].”
AI applications in prevalent diseases and disorders
Catania, L. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-824477-7.00007-9 · Cited by 12
Diabetic Gastroenteropathy: Soothe the Symptoms or Unravel a Cure?
Meling, S., Bertoli, D., Sangnes, D. A., Brock, C., Drewes, A. M., Ejskjær, N., Dimcevski, G. G., & Søfteland, E. W. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210322154618 · Cited by 12
Mechanism research on the interaction regulation of Escherichia and IFN-γ for the occurrence of T2DM
Lv, M.-J., Li, L., Li, W., Yang, F., Hu, Q., & Xiong, D. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-2318 · Cited by 12
“Studies have shown that hyperglycemia can cause oxidative stress on T-lymphocytes by activating reactive oxygen species and protein kinase C, which promote the secretion of cytokines and progression of inflammation causing damage to cellular immune function (13).”
BackgroundGerson, K. D., Liao, J., McCarthy, C., Burris, H. H., Korem, T., Levy, M., Ravel, J., & Elovitz, M. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-02304-0 · Cited by 12
Self-citationLi, J., Liu, X., Wu, Y., Ji, W., Tian, Q., & Li, S. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.075 · Cited by 12
Bagyánszki, M., & Bódi, N. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i18.2704 · Cited by 11
Li, T., Han, B., Wang, L., Sun, L., Cai, Y., Yu, M., Xiao, W., & Yang, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04789-x · Cited by 11
“…colitis: streptozocin-induced Type1 Diabetes mice (endogenous insulin deficiency) exhibited significant exacerbation of colitis and hyperglycemia (relative inhibition of the insulin pathway) is a direct cause of disruption of the intestinal barrier and exacerbation of enteric infections [74].”
BackgroundSakamoto, Y., Niwa, M., Muramatsu, K., & Shimo, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031165 · Cited by 13
“For instance, regarding immunity, there are reports of the hyperglycemia-induced impairment of intestinal epithelial barrier function, innate immunity, and cellular immunity [24,42].”
BackgroundThe emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation
Khuat, L. T., Dave, M., & Murphy, W. J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1966262 · Cited by 13
Hua, X., Li, B., Yu, F., Zhao, W., Tan, Y., Li, X., Fu, C., Yu, X., Gao, H., & Cheng, M. (2022) · Nutrients · doi:10.3390/nu14030604 · Cited by 11
“Longstanding hyperglycemia leads to potentially destructive biochemical and physiological consequences throughout the body through the accumulation of AGEs [13].”
BackgroundGiacconi, R., D’Aquila, P., Malavolta, M., Piacenza, F., Bürkle, A., Moreno‐Villanueva, M., Dollé, M. E. T., Jansen, E. H. J. M., Grune, T., Gonos, E. S., et al. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac154 · Cited by 11
“There are many causes that can affect intestinal barrier permeability including hyperglycemia, increased alcohol consumption, chronic liver disease, alterations in epithelial stem cell turn over, mucus layer thickness, and tight junctions disruption (52).”
BackgroundSystemic Factors Affecting Human Beta-Defensins in Oral Cavity
Atalay, N., Balcı, N., Gürsoy, M., & Gürsoy, U. K. (2024) · Pathogens · doi:10.3390/pathogens13080654 · Cited by 10
“Hyperglycemia, the main pathological hallmark of diabetes mellitus, markedly interferes with homeostatic epithelial integrity, leading to an abnormal influx of immune-stimulatory microbial products [50,51].”
Puértolas-Balint, F., K., V., Holmberg, S. M., & Schroeder, B. O. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2536095 · Cited by 10
“As hyperglycemia has been previously associated with intestinal epithelial cell transcriptional reprogramming and impaired host intestinal barrier, 44 it is also possible that the WSD negatively impacts AMP function at specific sites of the small intestine.”
Reduced gut microbiota diversity in patients with congenital generalized lipodystrophy
Montenegro, R. M., Ponte, C. M. M., Castelo, M. H. C. G., Silveira, A. C. D. O., Fernandes, V. O., d’Alva, C. B., de Oliveira, L. F. V., Hristov, A. D., Bandeira, S. P., Paiva, G. E. D. C., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00908-8 · Cited by 11
“This effect promotes increased mucosal permeability, leading to the "leaky gut" associated with bacterial translocation [59].”
BackgroundRecent advances in the mechanism of hydrogen sulfide in wound healing in diabetes
Yang, F., Zhong, W., Pan, S., Wang, Y., Xiao, Q., & Gao, X. Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149343 · Cited by 11
Jingwen, Q., Wu, J., Chen, W., Ruan, Y., Mao, J., Li, S., Tang, X., Zhao, L. Q., Li, S., Li, K., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03654-y · Cited by 11
“…evidence suggests that diabetes compromises the integrity of the intestinal barrier, facilitating the translocation of microorganisms, their metabolites, and pathogen-associated molecular patterns (PAMPs), including lipopolysaccharide (LPS) and peptidoglycan (PGN), into the bloodstream [3].”
BackgroundHe, Y., Qu, C., Zhao, H., Wang, P., Zheng, Z., & Miao, J. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.103805 · Cited by 11
Yang, L., Gao, Y., Wang, H., Zhong, W., Gong, J., Farag, M. A., Zhao, Y., & Xiao, J. (2024) · Food Safety and Health · doi:10.1002/fsh3.12041 · Cited by 11
Tang, X., Chen, X., Ferrari, M. D. L., Walvoort, M. T. C., & de Vos, P. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300910 · Cited by 10
A breach in the intestinal barrier during hyperglycaemia
Ray, K. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.26 · Cited by 10
Kifle, Z. D., Woldeyohanins, A. E., & Demeke, C. A. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100137 · Cited by 11
“Metabolic syndrome such as DM is frequently related to increased systemic infection and leaky gut [83].”
Gaudreau, M., Gudi, R. R., Li, G., Johnson, B. M., & Vasu, C. (2021) · Autoimmunity · doi:10.1080/08916934.2021.2012165 · Cited by 10
“It is possible that, as suggested in previous reports[89-92], hyperglycemia alone can impact various physiological functions including gut permeability and cause systemic pro-inflammatory response aggravating the disease complications.”
BackgroundTao, W., Yu, Y., Tan, D., Huang, X., Huang, J., Lin, C., & Yu, R. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1603442 · Cited by 9
“As evidenced in db/db and ob/ob mouse models (Thaiss et al., 2018), sustained hyperglycemia activates intestinal epithelial glucose transporter 2 (GLUT2) and downregulates the expression of zonula occludens-1 (ZO-1), increasing intestinal permeability.”
Mechanism of interdigitation formation at apical boundary of MDCK cell
Miyazaki, S., Otani, T., Sugihara, K., Fujimori, T., Furuse, M., & Miura, T. (2023) · iScience · doi:10.1016/j.isci.2023.106594 · Cited by 9
“High glucose stimulus induces interdigitation of tight junction and barrier dysfunction of small intestine epithelium.(7)”
BackgroundShin, J. H., Bozadjieva-Kramer, N., Shao, Y., Mercer, A. J., Lyons‐Abbott, S., Awan, R., Lewis, A. G., & Seeley, R. J. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00132.2024 · Cited by 9
Feng, Y., Zhao, Q., Zhao, Y., Ma, C., Tian, M., Hu, X., Chen, F., & Li, D. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03504-w · Cited by 10
“A finely tuned inflammatory response is necessary to defend against C. rodentium -induced infection by enhancing gut barrier and limiting bacterial translocation [18].”
Oxidative Stress and Gut Microbiota Interplay Exacerbates Periodontitis in Diabetic Mice
Gong, H., Zhang, L., Liu, Y., Yuan, X., Liu, Y., Tang, J., Zhou, M., Song, J., & Zhang, T. (2025) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.70003 · Cited by 9
Šantić, R., Martinovic, L., Pavlović, N., Martinović, D., Vrdoljak, J., Kumrić, M., Vilović, M., & Božić, J. (2026) · Molecules · doi:10.3390/molecules31111840 · Cited by 9
“…loop: barrier dysfunction generates the endotoxin signal that initiates adipose and hepatic insulin resistance, while the resulting hyperglycemia and metabolic stress further compromise barrier integrity, perpetuating both endotoxemia and β -cell decline in a self-amplifying cycle [6,88,106].”
Lodi, K. Z., Cappelari, M. B., Pilatti, G. C., Fontana, R. C., Camassola, M., Salvador, M. M., & Branco, C. S. (2022) · Natural Product Research · doi:10.1080/14786419.2022.2110091 · Cited by 9
“The presence of high glucose acts as a modifier of the intestinal barrier, and the state of postprandial hyperglycemia in diabetic patients interferes negatively with the integrity of the epithelial mucosa (Thaiss et al. 2018).”
BackgroundChen, J., Zou, Y., Zheng, T., Huang, S., Guo, L., Lin, J., & Zheng, Q. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05785 · Cited by 10
Pokala, A., Quarles, W., Ortega‐Anaya, J., Jiménez‐Flores, R., Cao, S., Zeng, M., Hodges, J. K., & Bruno, R. S. (2023) · Nutrients · doi:10.3390/nu15143259 · Cited by 10
“Because hyperglycemia also promotes the systemic influx of microbial products from the gut [8], we examined postprandial excursions of plasma glucose and insulin in response to the test meal challenge and their relationship to serum endotoxin (Figure 4).”
BackgroundInfluentialThe Microbiota–Gut–Brain Axis and Diabetic Cognitive Impairment: A Memorable Journey
Rai, S., Sreelatha, S., Devang, N., Alva, P. D., & Raveendran, A. V. (2023) · Clinical Diabetology · doi:10.5603/dk.a2023.0025 · Cited by 10
The Intervention of Probiotics on Type 2 Diabetes Mellitus in Animal Models
Qu, Q., He, P., Zhang, Y., Yang, S., & Zeng, P. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200815 · Cited by 11
Restoring SRSF3 in Kupffer cells attenuates obesity-related insulin resistance
Gao, H., Rocha, K. C. E., Jin, Z., Kumar, D., Zhang, D., Wang, K., Das, M., Farrell, A., Truong, T., Tekin, Y., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000836 · Cited by 10
The Regulation Role of the Gut-Islets Axis in Diabetes
Yang, S., Cao, J., Sun, C., & Li, Y. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s455026 · Cited by 9
Association between gut microbiota and diabetic nephropathy: a mendelian randomization study
Jin, Y., Han, C., Yang, D., & Gao, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1309871 · Cited by 10
Recent advances in host-focused molecular tools for investigating host-gut microbiome interactions
Wang, S., Gong, X., Xiao, F., & Yang, Y. K. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1335036 · Cited by 11
Sellami, E., Evangelista-Silva, P. H., Teixeira, C. J., Diop, K., Mitchell, P., & Anhê, F. F. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102101 · Cited by 9
“In contrast, at earlier stages in the trajectory to obesity, it is possible that other factors, such as gut microbial dysbiosis [63] and hyperglycemia [64], can override Glp2 ’ s barrier reinforcing effects to yield a net impairment of gut barrier function.”
Giddings, H. J., Teodòsio, A., Jones, J., McMurray, J. L., Hunter, K. J., Alame, R., Gardiner, I., Abdawn, Z., Butterworth, W. A., Henderson, I. R., et al. (2025) · Helicobacter · doi:10.1111/hel.70016 · Cited by 12
“Bacterial invasion is associated with multiple diseases of the gastrointestinal tract, causing damage to the epithelial architecture by triggering inflammatory responses [15–17].”
Sánchez-Salguero, E. S., & Santos‐Argumedo, L. (2018) · Revista Alergia México · doi:10.29262/ram.v65i3.519 · Cited by 10
Tao, X., Tian, L., Zhan, H., He, Y., Zhong, C., & Wei, H. (2021) · Food Control · doi:10.1016/j.foodcont.2021.108079 · Cited by 9
Relationships between Diabetes and the Intestinal Microbial Population
Bondy, S. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010566 · Cited by 10
“The hyperglycemia that often precedes overt T2D has been found to disrupt the tight adherence and barrier function of the intestinal epithelial cells [53].”
BackgroundWeninger, S. N., Ding, A., Browne, E. N., Frost, M. L., Schiro, G., Laubitz, D., & Duca, F. A. (2023) · Metabolites · doi:10.3390/metabo13050660 · Cited by 9
“Alternatively, hyperglycemia is known to impair gut barrier function, allowing for increased bacterial translocation and significantly shifts the gut microbiota, which is restored following a return to normoglycemia via insulin [44].”
BackgroundHoughton, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713448 · Cited by 9
“Such damage leads to insulin resistance and elevated HbA1c.”
BackgroundInfluentialArtificial Intelligent in Healthcare
Meiliana, A., Dewi, N. M., & Wijaya, A. (2019) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v11i2.844 · Cited by 10
“Calibrated continuous glucose sensors will precede the need for finger-stick glucose calibrations, and give an interesting fact that post-prandial glucose spikes commonly occur, even in healthy people without diabetes (85,86), suggesting an association with gastrointestinal barrier dysfunction (87,88) in experimental…”
BackgroundWang, S., Kai, L., Zhu, L., Xu, B., Chen, N., Valencak, T. G., Wang, Y., & Shan, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.685363 · Cited by 9
Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
Li, B., Gong, T., Hao, Y., Zhou, X., & Cheng, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.721249 · Cited by 9
“Stimuli capable of activating a range of TLR and NOD receptors were detected in serum from healthy individuals (42).”
BackgroundSerum Metabolome Mediates the Antiobesity Effect of Celastrol-Induced Gut Microbial Alterations
Xu, S., Lyu, L., Zhu, H., Huang, X., Xu, W., Xu, W., Feng, Y., & Fan, Y. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00513 · Cited by 9
Amini, S., Jafarirad, S., Abiri, B., Delgarm, P., Mohamad-Zadeh, Y., Ghomi, M., & Jahangirimehr, A. (2021) · The journal of nutrition health & aging · doi:10.1007/s12603-021-1707-2 · Cited by 9
“Dietary pattern with high rate of monosaccharides can lead to insulin resistance (29), elevation of oxidative stress, inflammation (30), and advanced glycation end products (31, 32), that increase many chronic diseases such as retinopathy.”
Live and Diet by Your Gut Microbiota
Bassis, C. M. (2019) · mBio · doi:10.1128/mbio.02335-19 · Cited by 9
“In a mouse model, hyperglycemia increased gut permeability and dissemination from the gut of a pathogen and probably of other members of the microbiota (9).”
BackgroundVisvanathan, R., Houghton, M. J., & Williamson, G. (2025) · Antioxidants · doi:10.3390/antiox14030253 · Cited by 8
“Supporting this notion, intestinal GLUT2 knockdown in mice was found to preserve gut integrity, reduce susceptibility to infection, modulate the gut microbiota composition and reduce systemic inflammation [38,39].”
Bruder‐Nascimento, A., & Bruder-Nascimento, T. B. (2025) · Comprehensive physiology · doi:10.1002/cph4.70018 · Cited by 8
“However, it also plays important roles in other functions, including reproduction (Childs et al. 2021), gut development (Thaiss et al. 2018), immune response (Fernandez-Riejos et al. 2010), and bone mineralization (Sienkiewicz et al. 2011).”
Jia, R. F., Xiao, C., Zhang, Y., Hu, L.-Y., Jun-jun, Y., Zuo, R., Hu, Y., Xie, Y.-H., Ma, X., Li, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101311 · Cited by 11
He, J., Xi, Y., Lam, H., Du, K., Chen, D., Dong, Z., & Xiao, J. (2023) · Journal of Diabetes Research · doi:10.1155/2023/8818502 · Cited by 8
“Studies have shown that glucose is the coordinator of intestinal barrier function, and the hyperglycemia in T2DM patients interferes with the integrity of the homeostasis epithelium, resulting in an abnormal inflow of immunologically stimulating microbial products and a tendency to systemic transmission of intestinal…”
BackgroundNarukawa, Y., Sugiyama, N., Miura, J., Yamashita, R., Tominaga, S., Izumi, Y., Bamba, T., Ishihama, Y., Kashiwagi, Y., & Murakami, S. (2023) · Journal of Periodontal Research · doi:10.1111/jre.13140 · Cited by 8
Huh, E., Choi, J. G., Lee, M. Y., Kim, J. H., Choi, Y., Ju, I. G., Eo, H., Park, M. G., Kim, D.-H., Park, H., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1201073 · Cited by 9
“In particular, as there are several reports that intestinal barrier dysfunction is aggravated when the amount of glucose is increased or when the state of hyperglycemia is present (Thaiss et al., 2018; Zhang X. et al., 2021), changes in related metabolites may have also affected the action of intestinal pathology (Sup…”
BackgroundMogroside Alleviates Diabetes Mellitus and Modulates Intestinal Microflora in Type 2 Diabetic Mice
Qin, T., Li, Y., Wu, Y., Meng, F., Lin, G., & Xia, X. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00124 · Cited by 10
Xu, H., Zhang, T., Zhou, Z., Gao, T. X., Zhao, R., & Chen, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138341 · Cited by 10
Cai, Y., Yang, Q., Tang, X., Wang, P., Cui, J., Du, X., Zhang, T., & Chen, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551256 · Cited by 15
Ondee, T., Pongpirul, K., Wongsaroj, L., Senaprom, S., Wattanaphansak, S., & Leelahavanichkul, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-10435-x · Cited by 9
“For the carbohydrate-induced pro-inflammation, impacts of hyperglycemia-induced cell injury distribute to all cells in the body, despite the main sugar absorption site at the small intestine 83 .”
Gilliam‐Vigh, H., Ellegaard, A., Madsen, M. R., Lund, A., Jensen, B. A. H., Vilsbøll, T., Rigbolt, K. T. G., & Knop, F. K. (2025) · Gut · doi:10.1136/gutjnl-2024-334124 · Cited by 8
Matsumura, S., Kurashima, Y., Murasaki, S., Morimoto, M., Arai, F., Saito, Y., Katayama, N., Kim, D., Inagaki, Y., Kudo, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75186-3 · Cited by 8
[Effect of hypertension on outcomes of patients with COVID-19].
Chengyi, H. U., Xiao, L., Hongbo, Z., Zhang, Y.-P., Wenfeng, Z., Li, L., & Hong, Z. (2020) · PubMed · doi:10.12122/j.issn.1673-4254.2020.11.01 · Cited by 8
Nakatsu, G. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15715 · Cited by 10
Infection-elicited microbiota promotes host adaptation to nutrient restriction
Siqueira, M. K. D., Andrade‐Oliveira, V., Stacy, A., Guimarães, J. P. T., Alberca, R. W., Castoldi, Â., Santos, J. M., Davoli-Ferreira, M., Menezes-Silva, L., Turato, W. M., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214484120 · Cited by 10
“In contrast, dysregulated host metabolism can disrupt or alter the microbiota’s resistance to pathogens (19, 20), but to date, whether infection can in turn impact the microbiota’s regulation of host metabolism warrants further exploration.”
BackgroundBATF3 Protects Against Metabolic Syndrome and Maintains Intestinal Epithelial Homeostasis
Hamade, H., Stamps, J. T., Stamps, D. T., More, S. K., Thomas, L. S., Blackwood, A. Y., Lahcene, N. L., Castanon, S. L., Salumbides, B. C., Shimodaira, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841065 · Cited by 9
“Hyperglycemia has been demonstrated to markedly interfere with homeostatic intestinal epithelial barrier function by altering the expression and localization of adherence and tight junction proteins (22).”
BackgroundMésźaros, P., Kovács, S., Kulcsár, G., Páskuj, M., & Almási, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911913 · Cited by 11
“The hyperglycemia can form an intestinal barrier disfunction, thus causing an elevated permeability [35], although the paracetamol itself also can positively influence the membrane integrity [36], whereby the final result is to be dependent from the balance of the two factors.”
BackgroundMetabolic syndrome in combination with chronic kidney disease—It´s a gut feeling
Stenvinkel, P., & Shiels, P. G. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13363 · Cited by 8
Mojaddidi, M. A., Aboonq, M. S., & Alqahtani, S. A. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1577523 · Cited by 7
“This disruption facilitates the systemic in fl ux of microbial products, thereby increasing the risk of enteric infections and systemic in fl ammation (30).”
Jiang, T., Li, C., Pan, Z., Wang, Y., Chen, X., Song, J., Zhu, K., Yang, Y., Hou, Y., Sun, L., et al. (2025) · Diabetes · doi:10.2337/db25-0471 · Cited by 7
Zhang, L., Zhao, L., Hu, Y., Xiao, M., Zheng, Y., Wei, X., Xiao, C., & Zhou, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-27937-3 · Cited by 7
“Enterococcus and Enterobacter are facultative anaerobic bacteria, often considered as conditioned pathogens, which promote bacterial translocation and initiate inflammatory responses 17–20 .”
InfluentialBile acids and gut microbiota: interactions and impacts on polycystic ovary syndrome
Qian, H., Tao, J., Shi, L., Haiyan, S., Yang, L., Cui, L. J., Xu, W., & Wang, L. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1702198 · Cited by 8
“In non-PCOS animal studies, GM has been shown to affect systemic metabolism by altering the intestinal epithelial barrier, leading to accumulation of bacterial endotoxins (Cani et al., 2008; Thaiss et al., 2018).”
Tsakiridis, E. E., & Steinberg, G. R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70624 · Cited by 9
Nogueira, S., Barbosa, J., Faria, J., Sá, S. I., Cardoso, A., Soares, R. A., Fonseca, B. M., & Leal, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810984 · Cited by 7
“Overnutrition is recognized as a main driver of the chronic metabolic inflammation associated with the development of obesity and related metabolic disorders [3,5,8,51,52].”
BackgroundPanghal, A., & Jena, G. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230822151740 · Cited by 7
Huang, Z., Teng, W., Yao, L., Xie, K., Hang, S., He, R., & Li, Y. (2024) · BMC Molecular and Cell Biology · doi:10.1186/s12860-024-00509-5 · Cited by 9
“Intestinal epithelial cell GLUT2 knockout mice or by inhibiting glucose metabolism can improve the damage to intestinal epithelial model function induced by hyperglycemia and inhibit intestinal bacterial ectopic [45].”
BackgroundType 1 diabetes human enteroid studies reveal major changes in the intestinal epithelial compartment
Bharadiya, V. M., Rong, Y., Zhang, Z., Lin, R., Guerrerio, A. L., Tse, C., Donowitz, M., & Singh, V. (2024) · Scientific Reports · doi:10.1038/s41598-024-62282-x · Cited by 7
Hu, L., Xu, Y., Li, J., Zhang, M., Sun, Z., Ban, Y., Tian, X., Liu, D., & Hu, L. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1369192 · Cited by 7
“It may affect the intestinal barrier through “ leaky gut ” and “ molecular mimicry ” mechanisms and impact the host metabolism in in fl ammatory and autoimmune diseases (Benvenga and Guarneri, 2016; Thaiss et al., 2018).”
BackgroundMechanisms of Insulin Signaling as a Potential Therapeutic Method in Intestinal Diseases
Jarmakiewicz-Czaja, S., Sokal-Dembowska, A., Ferenc, K., & Filip, R. (2024) · Cells · doi:10.3390/cells13221879 · Cited by 8
“A state of elevated blood glucose may cause increased intestinal permeability through glucose transporter 2 (GLUT2)- dependent transcriptional reprogramming of the intestinal epithelium and alteration of tight junction integrity and adhesion [54].”
Matos, G. A., Nunes‐Costa, D., Pinto, D. V., Martins, C. S., Silva, J. L., Leocádio, P. C. L., Andrade, M. E. R., Raposo, R. D. S., Tiago, I., Alarico, S., et al. (2025) · Environmental Toxicology · doi:10.1002/tox.24469 · Cited by 7
“Interestingly, fucose associated with that terminal glycan chain of the intestinal Mucin2 has anti-inflammatory effect in colitis [36, 39].”
Emílio-Silva, M. T., Rodrigues, V. P., Fioravanti, M. M., Ruiz‐Malagón, A. J., Fioretto, M. N., Raimundo, P. R., Ohara, R., Assunção, R., Bueno, G. M., Dario, F. L., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1567217 · Cited by 7
“Metabolic endotoxemia caused by gut dysbiosis in obese individuals plays an important role in triggering low-grade chronic in fl ammation and metabolic dysfunction (Mohammad and Thiemermann, 2021; Thaiss et al., 2018).”
Niu, J., Liu, Y., Peng, H., Chen, J., & Chen, L. (2025) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-025-06906-6 · Cited by 7
“Hyperglycemia can disrupt the gut barrier integrity, facilitating systemic translocation of microbial components and increasing susceptibility to intestinal infections [17].”
Halatchev, I. G., O’Donnell, D., Hibberd, M. C., & Gordon, J. I. (2019) · Microbiome · doi:10.1186/s40168-019-0769-4 · Cited by 9
Intestinal Dysbiosis and Non-Alcoholic Fatty Liver Disease
Auguet, T., Bertran, L., & Binetti, J. (2021) · Biochemistry · doi:10.5772/intechopen.92972 · Cited by 7
“After disruption of the gut epithelial barrier, the liver is exposed to microbial products and metabolites resulting from bacterial metabolism [47, 48].”
BackgroundRuggiero, A. D., Vemuri, R., DeStephanis, D., Brock, A., Block, M. R., Chou, J., Das, S. K., Williams, A. G., & Kavanagh, K. (2023) · Obesity · doi:10.1002/oby.23870 · Cited by 8
Risk of infection in older adults with type 2 diabetes with relaxed glycemic control
Lipska, K. J., Gilliam, L. K., Lee, C., Liu, J. Y., Liu, V. X., Moffet, H. H., Parker, M. M., Zapata, H., & Karter, A. J. (2024) · Diabetes Care · doi:10.2337/dc24-1612 · Cited by 7
Bellenger, J., Bellenger, S., Bourragat, A., Escoula, Q., Weill, P., & Narce, M. (2021) · OCL · doi:10.1051/ocl/2021006 · Cited by 7
Beardsall, K., Thomson, L., Guy, C., Bond, S. J., Allison, A., Pantaleo, B., Petrou, S., Kim, S. W., Dunger, D. B., & Hovorka, R. (2021) · Efficacy and Mechanism Evaluation · doi:10.3310/eme08160 · Cited by 8
Ardizzone, A., Lanza, M., Casili, G., Campolo, M., Paterniti, I., Cuzzocrea, S., & Esposito, E. (2022) · Nutrients · doi:10.3390/nu14112251 · Cited by 8
“Excessive consumption of carbohydrates leads to intestinal disorders characterized by intestinal dysregulated morphology, accompanied by high intestinal permeability and loss of tissue epithelial integrity [39].”
BackgroundStähli, B. E., Scharl, M. M., & Matter, C. M. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad367 · Cited by 7
Zhang, Y., Chen, S., Chen, G., Zhou, L., Zhou, G., Yu, X., Yuan, L., Deng, W., Wang, Z., Li, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202413296 · Cited by 12
Giacconi, R., D’Aquila, P., Olivieri, F., Gentilini, D., Calzari, L., Fortunato, C., Pazmay, G. V. B., Rosa, M. D., Sena, G., Rose, E. D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146564 · Cited by 6
“This pattern suggests a synergistic interaction between diabetes and renal dysfunction that may amplify gut permeability [45], systemic inflammation, and the accumulation of circulating bacterial products.”
Erickson, D., Chua, M. J., Sheneman, K. R., Hernandez, L., & Collins, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2566302 · Cited by 6
Kimura, Y., Minoda, Y., Ihara, E., Ogino, H., Inamura, K., Bai, X., Tanaka, Y., Chinen, T., Sakamoto, R., Nakayama, J., et al. (2025) · Journal of Gastroenterology · doi:10.1007/s00535-025-02325-w · Cited by 6
Jalleh, R. J., Wu, T., Umapathysivam, M. M., Young, R. L., Jones, K. L., Marathe, C. S., Rayner, C. K., Plummer, M. P., & Horowitz, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00009.2025 · Cited by 6
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.